Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 270

    Mercks Keytruda shows promise in treating advanced melanoma

    Merck's Keytruda shows promise in treating advanced melanoma

    Ruby Khatun Khatun8 Jun 2018 9:45 AM IST
    Merck & Co Inc said long-term data from its cancer immunotherapy Keytruda showed promise in treating advanced melanoma patients, a day after...
    EMA issues measures to minimize liver damage risk from Richters Esmya

    EMA issues measures to minimize liver damage risk from Richter's Esmya

    Ruby Khatun Khatun8 Jun 2018 9:30 AM IST
    European Medicines Agency (EMA) issued guidelines to help minimize the risk of rare but serious liver injury associated with Hungarian drugmaker...
    Sahajanand Medical Technologies to start S-Flex Registry in Netherlands

    Sahajanand Medical Technologies to start S-Flex Registry in Netherlands

    Ruby Khatun Khatun7 Jun 2018 10:45 AM IST
    Mumbai / Netherlands: SMT (Sahajanand Medical Technologies Pvt. Ltd.), India’s largest manufacturer of cardiovascular medical stents, announced the...
    Lupin gets USFDA nod to market fungal infection cream

    Lupin gets USFDA nod to market fungal infection cream

    Ruby Khatun Khatun7 Jun 2018 10:30 AM IST
    New Delhi: Drug firm Lupin said it has received final approval from the US health regulator to market its Nystatin and Triamcinolone Acetonide cream...
    USFDA issues no observation on Zydus Ahmedabad facility

    USFDA issues no observation on Zydus Ahmedabad facility

    Ruby Khatun Khatun7 Jun 2018 10:15 AM IST
    New Delhi: Zydus Cadila’s wholly-owned subsidiary Alidac Pharmaceuticals has not received any observation from the US health regulator after the...
    MSME, AYUSH ministries to develop traditional medicine enterprises

    MSME, AYUSH ministries to develop traditional medicine enterprises

    Ruby Khatun Khatun7 Jun 2018 10:00 AM IST
    New Delhi: Ministries of MSME and AYUSH joined hands for developing enterprises in the traditional medicine sector."The memorandum of understanding...
    Novartis, aiming to go toe-to-toe with Humira, wins EU panel nod

    Novartis, aiming to go toe-to-toe with Humira, wins EU panel nod

    Ruby Khatun Khatun7 Jun 2018 9:45 AM IST
    ZURICH: Novartis’s generics unit won a European panel’s recommendation for its biosimilar version of AbbVie’s Humira as the Swiss drugmaker aims to...
    Imerys unit settles talc claims for at least 5 million dollar : Bloomberg

    Imerys unit settles talc claims for at least 5 million dollar : Bloomberg

    Ruby Khatun Khatun7 Jun 2018 9:30 AM IST
    A unit of French minerals company Imerys SA settled claims by 22 women related to talc supplied to Johnson and Johnson for making baby powder for at...
    Lupin launches generic drug to control postpartum hemorrhage in US

    Lupin launches generic drug to control postpartum hemorrhage in US

    Ruby Khatun Khatun6 Jun 2018 10:45 AM IST
    New Delhi: Drug maker Lupin launched Methylergonovine Maleate tablets, used for prevention and control of postpartum hemorrhage, in the American...
    USFDA approves Mylan, Biocon

    USFDA approves Mylan, Biocon's Fulphila, the first biosimilar to Neulasta

    Ruby Khatun Khatun6 Jun 2018 10:30 AM IST
    HERTFORDSHIRE/PITTSBURGH and BENGALURU: Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Mylan's...
    Unichem Labs Ghaziabad unit gets EIR from USFDA

    Unichem Lab's Ghaziabad unit gets EIR from USFDA

    Ruby Khatun Khatun6 Jun 2018 10:15 AM IST
    New Delhi: Drug firm Unichem Laboratories said its facility at Ghaziabad has received establishment inspection report (EIR) from the US health...
    Senior Marketing Director-Biocon, Vasudev Tribhuvan, joins Wellthy Therapeutics

    Senior Marketing Director-Biocon, Vasudev Tribhuvan, joins Wellthy Therapeutics

    Ruby Khatun Khatun6 Jun 2018 10:00 AM IST
    Mumbai: Wellthy Therapeutics (Wellthy) announced the appointment of Vasudev V. Tribhuvan as Vice President, Partnerships & Alliances effective May...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    300,000 doses of Mercks Ebola shot available for emergencies: GAVI Vaccine Alliance

    300,000 doses of Merck's Ebola shot available for emergencies: GAVI Vaccine Alliance

    German drug assessment body not convinced by Bayers cancer drug Vitrakvi

    German drug assessment body not convinced by Bayer's cancer drug Vitrakvi

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok